MedTrace Logo

Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration

NCT02219997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-05-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the reaction time (as measured by braking reaction time in seconds during simulated driving) under glare and no-glare conditions in subjects implanted with ACRYSOF® IQ intraocular lenses (IOLs) to subjects implanted with clear IOLs. This study will enroll subjects previously implanted with IOLs in both eyes for at least 3 months.

Conditions

  • Cataract

Interventions

DEVICE

Clear clip-on glasses

Clip-on glasses with no blue light filtering properties used as a placebo

DEVICE

Blue light filter clip-on glasses

Clip-on glasses with blue light filtering properties similar to ACRYSOF® IOLs

DEVICE

ACRYSOF® IQ IOL

AcrySof IQ Aspheric Natural IOL Model SN60WF with UV and blue light filtering properties, previously implanted

DEVICE

Clear IOL

Clear IOL, previously implanted

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Sr Clinical Manager, GCRA-Global Med Affairs, Operations · Alcon Research

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02219997 on ClinicalTrials.gov